Literature DB >> 2288395

Mastocytosis and atopy: a study of 33 patients with urticaria pigmentosa.

U Müller1, A Helbling, T Hunziker, B Wüthrich, A Pécoud, S Gilardi, E Beretta, J Fasel, W Messerli, P Maurer.   

Abstract

Thirty-three patients with histologically verified urticaria pigmentosa were studied for coexisting atopic disease by means of history, skin prick testing with five common inhalants and serological investigation for total IgE and specific IgE antibodies to five common inhalants. The prevalence of atopy in urticaria pigmentosa was similar to that observed in the normal Swiss population, both on the basis of history (7/33 = 21%) and of positive skin prick tests to common inhalants (12/33 = 36%). However, total serum IgE levels were significantly lower (geometric mean value 16.8 kU/l) than in a control group of 52 Swiss blood donors of comparable age and sex distribution (geometric mean value 43.0 kU/l, t = 2.93, P less than 0.005). Specific IgE antibodies to common inhalants were also observed less frequently in urticaria pigmentosa patients than in controls, although this difference was not statistically significant. Low total and specific IgE values in patients with urticaria pigmentosa may be explained by increased absorption of circulating IgE to abundant tissue mast cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2288395     DOI: 10.1111/j.1398-9995.1990.tb00945.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  9 in total

1.  Paediatric mastocytosis.

Authors:  M C Carter; D D Metcalfe
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

2.  Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.

Authors:  Melody C Carter; Sarah T Clayton; Hirsh D Komarow; Erica H Brittain; Linda M Scott; Daly Cantave; Donna M Gaskins; Irina Maric; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2015-06-01       Impact factor: 10.793

Review 3.  Component Resolved Diagnosis in Hymenoptera Anaphylaxis.

Authors:  D Tomsitz; K Brockow
Journal:  Curr Allergy Asthma Rep       Date:  2017-06       Impact factor: 4.806

Review 4.  Current approach to cutaneous mastocytosis in childhood.

Authors:  Zeynep Tamay; Deniz Özçeker
Journal:  Turk Pediatri Ars       Date:  2016-09-01

5.  Identification of alpha-gal sensitivity in patients with a diagnosis of idiopathic anaphylaxis.

Authors:  M C Carter; K N Ruiz-Esteves; L Workman; P Lieberman; T A E Platts-Mills; D D Metcalfe
Journal:  Allergy       Date:  2017-12-27       Impact factor: 13.146

Review 6.  Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?

Authors:  A Matito; M Carter
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

Review 7.  The problem of anaphylaxis and mastocytosis.

Authors:  Ulrich R Müller; Gabrielle Haeberli
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

8.  Abnormal bone marrow histopathology in paediatric mastocytosis.

Authors:  Melody C Carter; Dean D Metcalfe; Alicia S Clark; Alan S Wayne; Irina Maric
Journal:  Br J Haematol       Date:  2014-11-28       Impact factor: 8.615

9.  Twelve-hour ultrarush immunotherapy in a patient with mastocytosis and hymenoptera sting anaphylaxis.

Authors:  Doris Jäger; Jürgen Barth
Journal:  World Allergy Organ J       Date:  2009-03       Impact factor: 4.084

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.